Mohyuddin, G. R., Chakraborty, R., & Cliff, E. R. S. (2023). The promise and harms of screening for plasma cell dyscrasias. British Journal of Haematology, 200(6), 704–707. Portico. https://doi.org/10.1111/bjh.18634

Cicero, K. I., Joffe, M., Patel, M., Chiuzan, C., Pentz, A., Ruff, P., Lentzsch, S., Leng, S., Jacobson, J. S., Rebbeck, T. R., & Neugut, A. I. (2022). Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiology, Biomarkers & Prevention, 31(12), 2192–2198. https://doi.org/10.1158/1055-9965.epi-22-0525

Chakraborty, R., Bhutani, D., & Lentzsch, S. (2022). How do we manage t(11;14) plasma cell disorders with venetoclax? British Journal of Haematology, 199(1), 31–39. Portico. https://doi.org/10.1111/bjh.18243

Javaugue, V., Valeri, A. M., Jaffer Sathick, I., Said, S. M., Erdogan Damgard, S., Murray, D. L., Klobucher, T., Andeen, N. K., Sethi, S., Fervenza, F. C., Leung, N., & Nasr, S. H. (2022). The characteristics of seronegative and seropositive non-hepatitis-associated cryoglobulinemic glomerulonephritis. Kidney International, 102(2), 382–394. https://doi.org/10.1016/j.kint.2022.03.030